5631 - 5640 of 5857 Results
Title
Year
- Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?2010OPENTitle: Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?Journal Name: Rambam Maimonides Medical JournalPublisher: Rambam Health CorporationVol: 1Issue #: 2Start Page: e0011End Page: e0011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.5041/rmmj.10011Best OA location URL: https://www.rmmj.org.il/userimages/13/0/PublishFiles/13Article.pdfCitation Count: 8
-
OPENTitle: A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptorsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/ncomms1085Best OA location URL: https://www.nature.com/articles/ncomms1085.pdfCitation Count: 149
- Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis2010OPENTitle: Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 82Issue #: 5Start Page: 564End Page: 568Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp.2010.222042Best OA location URL: https://europepmc.org/articles/pmc4646086?pdf=renderCitation Count: 98
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://europepmc.org/articles/pmc3159957?pdf=renderCitation Count: 81
- Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats2010OPENTitle: Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 60Issue #: 2-3Start Page: 284End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2010.09.011Best OA location URL: https://europepmc.org/articles/pmc3820002?pdf=renderCitation Count: 20
- Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease2010OPENTitle: Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 226Issue #: 1Start Page: 207End Page: 217Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2010.09.001Best OA location URL: https://europepmc.org/articles/pmc3108022?pdf=renderCitation Count: 55
-
OPENTitle: Heterogeneous neuropathological findings in Parkinson’s disease with mild cognitive impairmentJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 120Issue #: 6Start Page: 827End Page: 828Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-010-0744-4Best OA location URL: https://europepmc.org/articles/pmc3100801?pdf=renderCitation Count: 79
- Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease2010OPENTitle: Deletion of adenosine A1 or A2A receptors reduces l-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's diseaseJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1367Issue #:Start Page: 310End Page: 318Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.08.099Best OA location URL: https://europepmc.org/articles/pmc3005012?pdf=renderCitation Count: 48
-
OPENTitle: CSF Aβ42 and tau in Parkinson's disease with cognitive impairmentJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2682End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23287Best OA location URL: https://europepmc.org/articles/pmc2978754?pdf=renderCitation Count: 168
-
OPENTitle: LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2536End Page: 2541Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23314Best OA location URL: https://europepmc.org/articles/pmc2978749?pdf=renderCitation Count: 62